BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thurman AR, Doncel GF. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention. Int J STD AIDS 2012;23:613-9. [PMID: 23033511 DOI: 10.1258/ijsa.2012.011356] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Govender Y, Morrison CS, Chen P, Gao X, Yamamoto H, Chipato T, Anderson S, Barbieri R, Salata R, Doncel GF, Fichorova RN. Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion. Sex Transm Infect. [DOI: 10.1136/sextrans-2022-055458] [Reference Citation Analysis]
2 Fernandez OE, Gudipati S, Ko D, Boucher A, Brar I. Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus. Clin Infect Dis 2022;75:172-5. [PMID: 36008926 DOI: 10.1093/cid/ciab853] [Reference Citation Analysis]
3 Govender Y, Morrison C, Chen P, Gao X, Yamamoto H, Chipato T, Anderson S, Barbieri R, Salata R, Doncel GF, Fichorova RN. Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion.. [DOI: 10.1101/2022.02.13.22270917] [Reference Citation Analysis]
4 Oeyen M, Noppen S, Vanhulle E, Claes S, Myrvold BO, Vermeire K, Schols D. A unique class of lignin derivatives displays broad anti-HIV activity by interacting with the viral envelope. Virus Res 2019;274:197760. [PMID: 31618614 DOI: 10.1016/j.virusres.2019.197760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Bernstein DI, Morello CS, Cardin RD, Bravo FJ, Kraynyak KA, Spector DH. A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2. Vaccine 2020;38:79-89. [PMID: 31611098 DOI: 10.1016/j.vaccine.2019.09.090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Farr Zuend C, Nomellini JF, Smit J, Horwitz MS. Generation of a Dual-Target, Safe, Inexpensive Microbicide that Protects Against HIV-1 and HSV-2 Disease. Sci Rep 2018;8:2786. [PMID: 29434285 DOI: 10.1038/s41598-018-21134-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
7 Zampese MS, Garbin GC, Rech BG. Skin Manifestations Associated with HIV/AIDS. Dermatology in Public Health Environments 2018. [DOI: 10.1007/978-3-319-33919-1_41] [Reference Citation Analysis]
8 Manguro GO, Masese LN, Deya RW, Magaret A, Wald A, McClelland RS, Graham SM. Genital HSV Shedding among Kenyan Women Initiating Antiretroviral Therapy. PLoS One 2016;11:e0163541. [PMID: 27683204 DOI: 10.1371/journal.pone.0163541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ragupathy V, Xue W, Tan J, Devadas K, Gao Y, Hewlett I. Progesterone augments cell susceptibility to HIV-1 and HIV-1/HSV-2 co-infections. J Mol Endocrinol 2016;57:185-99. [PMID: 27538988 DOI: 10.1530/JME-16-0138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
10 Donalisio M, Quaranta P, Chiuppesi F, Pistello M, Cagno V, Cavalli R, Volante M, Bugatti A, Rusnati M, Ranucci E, Ferruti P, Lembo D. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice. Biomaterials 2016;85:40-53. [PMID: 26854390 DOI: 10.1016/j.biomaterials.2016.01.055] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
11 Gordts SC, Férir G, D'huys T, Petrova MI, Lebeer S, Snoeck R, Andrei G, Schols D. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications. PLoS One 2015;10:e0131219. [PMID: 26132818 DOI: 10.1371/journal.pone.0131219] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
12 Malcolm RK, Boyd P, McCoy CF, Murphy DJ. Beyond HIV microbicides: multipurpose prevention technology products. BJOG 2014;121 Suppl 5:62-9. [PMID: 25335842 DOI: 10.1111/1471-0528.12852] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
13 Sánchez-Rodríguez J, Vacas-Córdoba E, Gómez R, De La Mata FJ, Muñoz-Fernández MÁ. Nanotech-derived topical microbicides for HIV prevention: the road to clinical development. Antiviral Res 2015;113:33-48. [PMID: 25446339 DOI: 10.1016/j.antiviral.2014.10.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
14 Jespers V, Millwood IY, Poynten IM, Van Damme L, Kaldor JM. The evolving design and methods for trials evaluating the safety of candidate vaginal microbicides: a systematic review. Sex Transm Dis 2013;40:729-36. [PMID: 23945427 DOI: 10.1097/01.olq.0000431070.38601.03] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
15 Quintana VM, Torres NI, Wachsman MB, Sinko PJ, Castilla V, Chikindas M. Antiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosin. J Appl Microbiol 2014;117:1253-9. [PMID: 25087911 DOI: 10.1111/jam.12618] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
16 Venkatesh KK, Cu-uvin S. Anatomic and Hormonal Changes in the Female Reproductive Tract Immune Environment during the Life Cycle: Implications for HIV/STI Prevention Research. Am J Reprod Immunol 2014;71:495-504. [DOI: 10.1111/aji.12247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
17 Des Jarlais DC, McKnight C, Arasteh K, Feelemyer J, Perlman DC, Hagan H, Dauria EF, Cooper HL. A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City. Subst Use Misuse 2014;49:783-92. [PMID: 24502371 DOI: 10.3109/10826084.2014.880176] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
18 Rollenhagen C, Lathrop MJ, Macura SL, Doncel GF, Asin SN. Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides. Mucosal Immunol 2014;7:1165-74. [PMID: 24496317 DOI: 10.1038/mi.2014.3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
19 Zhu XP, Muhammad ZS, Wang JG, Lin W, Guo SK, Zhang W. HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine. Viruses 2014;6:371-90. [PMID: 24469503 DOI: 10.3390/v6020371] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
20 Thurman AR, Clark MR, Hurlburt JA, Doncel GF. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. Int J Womens Health 2013;5:695-708. [PMID: 24174884 DOI: 10.2147/IJWH.S34030] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 6.7] [Reference Citation Analysis]
21 Balzarini J, Andrei G, Balestra E, Huskens D, Vanpouille C, Introini A, Zicari S, Liekens S, Snoeck R, Holý A, Perno CF, Margolis L, Schols D. A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity. PLoS Pathog 2013;9:e1003456. [PMID: 23935482 DOI: 10.1371/journal.ppat.1003456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
22 Férir G, Petrova MI, Andrei G, Huskens D, Hoorelbeke B, Snoeck R, Vanderleyden J, Balzarini J, Bartoschek S, Brönstrup M, Süssmuth RD, Schols D. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS One 2013;8:e64010. [PMID: 23724015 DOI: 10.1371/journal.pone.0064010] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 10.8] [Reference Citation Analysis]